Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,300
Closed -$543K 289
2022
Q3
$543K Hold
6,300
0.07% 138
2022
Q2
$574K Sell
6,300
-72,800
-92% -$6.45M 0.07% 193
2022
Q1
$6.49M Sell
79,100
-70,000
-47% -$5.52M 0.18% 113
2021
Q4
$11.4M Buy
149,100
+109,800
+279% +$8.75M 0.23% 75
2021
Q3
$2.95M Buy
+39,300
New +$2.99M 0.09% 222
2021
Q2
Sell
-17,502
Closed -$1.29M 1212
2021
Q1
$1.29M Sell
17,502
-63,928
-79% -$4.72M 0.03% 532
2020
Q4
$6.36M Hold
81,430
0.12% 160
2020
Q3
$6.45M Buy
+81,430
New +$6.38M 0.24% 100
2018
Q1
Sell
-15,720
Closed -$844K 113
2017
Q4
$844K Buy
+15,720
New +$871K 0.28% 58

Other funds holding MRK

SG3 Management's MRK Position: Q3 2021 in Review

SG3 Management sold out of Merck (MRK) in Q3 2021, closing a stake of 15,000 shares — an estimated $1.14M sold.

SG3 Management first reported a position in MRK in Q3 2020 and held it in 3 quarters. The position peaked at $1.64M in Q4 2020. 2,647 funds tracked by Wall St. Rank hold MRK as of Q3 2021.

  • SG3 Management reported no remaining Merck position as of Q3 2021 after selling out during the quarter.
  • SG3 Management sold 15,000 Merck shares in Q3 2021, an estimated $1.14M.
  • SG3 Management first reported a position in Merck in Q3 2020 and held it in 3 quarters.
  • SG3 Management's Merck position peaked at $1.64M in Q4 2020.
  • 2,647 funds tracked by Wall St. Rank held Merck as of Q3 2021.

Based on SG3 Management's 13F filing for Q3 2021, filed 15 Nov 2021.